Mereo BioPharma Group Statistics
Total Valuation
MREO has a market cap or net worth of $576.22 million. The enterprise value is $502.38 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MREO has 154.90 million shares outstanding. The number of shares has increased by 12.33% in one year.
Current Share Class | n/a |
Shares Outstanding | 154.90M |
Shares Change (YoY) | +12.33% |
Shares Change (QoQ) | +8.20% |
Owned by Insiders (%) | 3.27% |
Owned by Institutions (%) | 41.05% |
Float | 100.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 7.92 |
P/TBV Ratio | 8.03 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 502.38 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.10, with a Debt / Equity ratio of 0.09.
Current Ratio | 6.10 |
Quick Ratio | 5.83 |
Debt / Equity | 0.09 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -28.24 |
Financial Efficiency
Return on equity (ROE) is -62.11% and return on invested capital (ROIC) is -28.94%.
Return on Equity (ROE) | -62.11% |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -28.94% |
Revenue Per Employee | $30,303 |
Profits Per Employee | -$1.37M |
Employee Count | 33 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -532,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +63.16% in the last 52 weeks. The beta is 0.97, so MREO's price volatility has been similar to the market average.
Beta (5Y) | 0.97 |
52-Week Price Change | +63.16% |
50-Day Moving Average | 4.15 |
200-Day Moving Average | 3.75 |
Relative Strength Index (RSI) | 41.37 |
Average Volume (20 Days) | 818,621 |
Short Selling Information
Short Interest | 4.57M |
Short Previous Month | 5.16M |
Short % of Shares Out | 3.98% |
Short % of Float | n/a |
Short Ratio (days to cover) | 6.58 |
Income Statement
In the last 12 months, MREO had revenue of $1.00 million and -$45.32 million in losses. Loss per share was -$0.31.
Revenue | 1.00M |
Gross Profit | 1.27M |
Operating Income | -38.07M |
Pretax Income | n/a |
Net Income | -45.32M |
EBITDA | -37.48M |
EBIT | -38.07M |
Loss Per Share | -$0.31 |
Full Income Statement Balance Sheet
The company has $80.52 million in cash and $6.68 million in debt, giving a net cash position of $73.84 million or $0.48 per share.
Cash & Cash Equivalents | 80.52M |
Total Debt | 6.68M |
Net Cash | 73.84M |
Net Cash Per Share | $0.48 |
Equity (Book Value) | 72.54M |
Book Value Per Share | 0.47 |
Working Capital | 72.52M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -30.20M |
Capital Expenditures | n/a |
Free Cash Flow | -30.20M |
FCF Per Share | -$0.19 |
Full Cash Flow Statement Margins
Gross Margin | 127.30% |
Operating Margin | -3,806.60% |
Pretax Margin | -4,584.80% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MREO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12.33% |
Shareholder Yield | -12.33% |
Earnings Yield | -7.86% |
FCF Yield | -5.24% |
Analyst Forecast
The average price target for MREO is $7.50, which is 101.61% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $7.50 |
Price Target Difference | 101.61% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 60.72% |
EPS Growth Forecast (5Y) | -31.98% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MREO has an Altman Z-Score of 9.32 and a Piotroski F-Score of 2.
Altman Z-Score | 9.32 |
Piotroski F-Score | 2 |